Patients Want 2nd Circ. To Revive Pfizer Lipitor Suit
A group of patients who allege that Pfizer Inc.'s drug Lipitor caused their diabetes asked the Second Circuit to revive their case on Tuesday, saying their claims aren't preempted because the...To view the full article, register now.
Already a subscriber? Click here to view full article